What is a commercial paper program?

A commercial paper program is a facility that allows a company to issue short-term, unsecured promissory notes (known as commercial paper) to raise funds. These notes are typically sold at a discount to their face value and have maturities ranging from a few days to 397 days. It's a common way for large corporations to manage their short-term liquidity needs.

Why is HCA Healthcare establishing this program?

HCA Healthcare is establishing this program to gain flexible access to short-term funding for its general corporate purposes. This allows the company to manage its working capital efficiently, meet short-term obligations, and potentially take advantage of favorable market conditions for borrowing.

What does the guarantee from HCA Healthcare, Inc. mean for investors?

The unconditional guarantee from HCA Healthcare, Inc. (the parent company) for the commercial paper notes issued by its subsidiary significantly enhances the credit quality and security of the notes. It means that if the subsidiary is unable to meet its obligations, the parent company is legally bound to do so, reducing the risk for investors holding these notes.

Are these commercial paper notes publicly traded?

No, the commercial paper notes will be sold on a private placement basis in the U.S. commercial paper market. They are not registered under the Securities Act of 1933 and are not available through public stock exchanges. This means they are typically purchased by institutional investors and other sophisticated market participants.

HCA 8-K: Financial Events

Summary

HCA Healthcare, Inc. (HCA) has announced the establishment of a commercial paper program through its direct, wholly-owned subsidiary, HCA Inc. This program allows for the issuance of unsecured commercial paper notes up to a maximum aggregate principal amount of $4.0 billion outstanding at any time. The Parent Guarantor, HCA Healthcare, Inc., is providing an unconditional guarantee for these notes, indicating strong financial backing for this new financing facility. The primary purpose of this commercial paper program is to provide HCA with flexible access to short-term funding for general corporate purposes. The notes will have maturities of up to 397 days and will be sold on customary terms in the U.S. commercial paper market. Investors should note that this is a private placement and the securities are not registered under the Securities Act of 1933, meaning they are subject to specific exemptions from registration requirements. This move suggests a proactive approach by HCA to manage its liquidity and working capital needs.

Key Highlights

1HCA Healthcare establishes a new $4.0 billion commercial paper program through its subsidiary, HCA Inc.
2The program is backed by an unconditional guarantee from the parent company, HCA Healthcare, Inc.
3Proceeds from the commercial paper notes will be used for general corporate purposes, indicating flexibility in capital deployment.
4Maturities for the notes can extend up to 397 days, offering a stable short-term funding source.
5The commercial paper will be issued on a private placement basis and is not registered under the Securities Act of 1933.
6This initiative provides HCA with enhanced liquidity and efficient access to short-term financing.

HCA Healthcare, Inc. 8-K Report, Financial Obligation (Jun 10, 2025)

Summary

Key Highlights

Frequently Asked Questions